Unknown

Dataset Information

0

Evaluation of Toxicity and Efficacy of Inotodiol as an Anti-Inflammatory Agent Using Animal Model.


ABSTRACT: Chaga mushroom (Inonotus obliquus) comprises polyphenolic compounds, triterpenoids, polysaccharides, and sterols. Among the triterpenoid components, inotodiol has been broadly examined because of its various biological activities. The purpose of this study is to examine inotodiol from a safety point of view and to present the potential possibilities of inotodiol for medical usage. From chaga mushroom extract, crude inotodiol (INO20) and pure inotodiol (INO95) were produced. Mice were treated with either INO20 or INO95 once daily using oral administration for repeated dose toxicity evaluation. Serum biochemistry parameters were analyzed, and the level of pro-inflammatory cytokines in the serum was quantified. In parallel, the effect of inotodiol on food allergic symptoms was investigated. Repeated administration of inotodiol did not show any mortality or abnormalities in organs. In food allergy studies, the symptoms of diarrhea were ameliorated by administration with INO95 and INO20. Furthermore, the level of MCPT-1 decreased by treatment with inotodiol. In this study, we demonstrated for the first time that inotodiol does not cause any detrimental effect by showing anti-allergic activities in vivo by inhibiting mast cell function. Our data highlight the potential to use inotodiol as an immune modulator for diseases related to inflammation.

SUBMITTER: Nguyen TMN 

PROVIDER: S-EPMC9331631 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2016-03-02 | E-GEOD-78769 | biostudies-arrayexpress
2016-03-02 | GSE78769 | GEO
| S-EPMC7081170 | biostudies-literature
| S-EPMC5784895 | biostudies-literature
2023-09-30 | GSE239693 | GEO
| S-EPMC7866062 | biostudies-literature
| S-EPMC8255787 | biostudies-literature
| S-EPMC9582731 | biostudies-literature
2010-03-09 | GSE20690 | GEO
| S-EPMC4145829 | biostudies-other